H. Pralle

3.8k total citations
65 papers, 1.8k citations indexed

About

H. Pralle is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, H. Pralle has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 20 papers in Genetics and 11 papers in Oncology. Recurrent topics in H. Pralle's work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Myeloid Leukemia Research (12 papers). H. Pralle is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Myeloid Leukemia Research (12 papers). H. Pralle collaborates with scholars based in Germany, Austria and Nigeria. H. Pralle's co-authors include Rüdiger Hehlmann, Joerg Hasford, H. Löffler, H. Heimpel, W. Queißer, Andreas Hochhaus, B Heinze, HJ Kolb, DK Hossfeld and B. Kemkes‐Matthes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

H. Pralle

64 papers receiving 1.7k citations

Peers

Countries citing papers authored by H. Pralle

Since Specialization

Citations

This map shows the geographic impact of H. Pralle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Pralle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Pralle more than expected).

Fields of papers citing papers by H. Pralle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Pralle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Pralle. The network helps show where H. Pralle may publish in the future.

Co-authorship network of co-authors of H. Pralle

This figure shows the co-authorship network connecting the top 25 collaborators of H. Pralle. A scholar is included among the top collaborators of H. Pralle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Pralle. H. Pralle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Viszerale Leishmaniose mit ungewöhnlich langer Inkubationszeit 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Axel Matzdorff, K. Matthes, B. Kemkes‐Matthes, H. Pralle	6
2	Gender aspects in chronic myeloid leukemia: long-term results from randomized studies 2005 ·Leukemia ·Ute Berger, Ole Maywald, Markus Pfirrmann, Tanja Lahaye, Andreas Hochhaus, Andreas Reiter, Joerg Hasford, H. Heimpel, D. K. Hossfeld, H-J Kolb, H. Löffler, H. Pralle, W. Queißer, Rüdiger Hehlmann, (unknown)	54
3	Dendritic cells fused with core binding factor‐beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes 2004 ·British Journal of Haematology ·(unknown), (unknown), (unknown), (unknown), (unknown), H. Pralle	13
4	Core‐binding factor‐β positive acute myeloid leukaemia cells induce T‐cell responses 2003 ·British Journal of Haematology ·(unknown), (unknown), (unknown), (unknown), (unknown), H. Pralle	6
5	Advances in the treatment of hairy-cell leukaemia 2003 ·The Lancet Oncology ·Ulrich Mey, John Strehl, Marcus Gorschlüter, Carsten Ziske, Axel Glasmacher, H. Pralle, Ingo G.H. Schmidt‐Wolf	30
6	Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial 2003 ·Leukemia ·Richard F. Schlenk, Axel Benner, Frank Hartmann, F. del Valle, Christian Weber, H. Pralle, J. Th. Fischer, U. Gunzer, Antonio Pezzutto, William P. Weber, W. Grimminger, J. Preiß, M. Hensel, Stefan Fröhling, Konstanze Döhner, Rainer Haas, Hartmut Döhner, (unknown)	87
7	Tumour-induced suppression of immune response and its correction 2001 ·Cancer Immunology Immunotherapy ·Gamal-Andre Banat, Oliver Christ, B. Cochlovius, H. Pralle, Margot Zöller	17
8	Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro 2000 ·Journal of Laboratory and Clinical Medicine ·Axel Matzdorff, (unknown), B. Kemkes‐Matthes, H. Pralle, (unknown), Jawed Fareed	27
9	Therapierefraktäre ventrikuläre Tachykardien bei einer Patientin mit primärem kardialen Non-Hodgkin-Lymphom 2000 ·Medizinische Klinik ·Oliver Kohl, Hans Hölschermann, H. Pralle, (unknown), Rainer M. Bohle, J Thormann, (unknown)	10
10	Reactivity of Platelets from Healthy Individuals and from Patients with Hematologic Diseases following Incubation with Pegylated RecombinantHuman Megakaryocyte Gr owth and Development Factor in vitro 1998 ·Pathophysiology of Haemostasis and Thrombosis ·Axel Matzdorff, B. Kemkes‐Matthes, H. Pralle	2
11	Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony‐stimulating factor‐supported high‐dose cytarabine and mitoxantrone 1997 ·British Journal of Haematology ·R. Schlenk, Hartmut Döhner, (unknown), Axel Benner, (unknown), Frank Hartmann, J. Th. Fischer, William P. Weber, U. Gunzer, H. Pralle, (unknown)	21
12	Clinical Experience with Fludarabine and its Immunosuppressive Effects in Pretreated Chronic Lymphocytic Leukemias and Low-Grade Lymphomas 1995 ·Leukemia & lymphoma ·Klaus Fenchel, Lothar Bergmann, (unknown), (unknown), H. Pralle, Paris S. Mitrou, Volker Diehl, (unknown)	55
13	Increased risk of acute myelogeneous leukemia (AML) and chronic myelogenous leukemia (CML) in a county of Hesse, Germany 1993 ·Sozial- und Präventivmedizin ·Gerald Kolb, (unknown), (unknown), Gerhard Zugmaier, H. Pralle, Jürgen Wahrendorf, K. Havemann	17
14	Book reviews 1989 ·Annals of Hematology ·Klaus T. Preissner, (unknown), (unknown), H. Pralle, (unknown)	1
15	T-cell prolymphocytic leukemia (T-PLL) with unique surface phenotype 1987 ·Annals of Hematology ·(unknown), M. Hadam, Anthony D. Ho, (unknown), H. Pralle	4
16	High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis 1986 ·Annals of Hematology ·H. Breithaupt, H. Heckers, H. Pralle, (unknown), (unknown), V. Graef, Gernot Jundt	2
17	Therapy of Priapism in High Counting Myeloid Leukemia -A Combined Oncological-Urological Approach 1985 ·Urologia Internationalis ·(unknown), H. Pralle, W. Weidner	7
18	Therapie-Response verschiedener histologischer Subtypen des Osteosarkoms unter hochdosierter Methotrexat-Behandlung 1983 ·Oncology Research and Treatment ·Antonia Schulz, (unknown), H. Breithaupt, H. Pralle	4
19	Prognostic factors in COPP-treated patients with Hodgkin's disease 1982 ·Annals of Hematology ·W. Gaßmann, (unknown), Norbert Schmitz, (unknown), H. Pralle, H. L�ffler	1
20	Electron spin resonance (ESR) investigations on blood of patients with leukemia 1979 ·Annals of Hematology ·W. Lohmann, J. Schreiber, (unknown), H. Breithaupt, H. L�ffler, H. Pralle	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact